Dentium

145720 · KOSPI · Health Care · SMALL CAP

Revenue down 15% in FY2025.

Dentium reported consolidated results for FY2025: revenue of US$239M (−15% year on year), operating profit of US$44.2M (−34.9% year on year) and net income of US$11.5M (−76.9% year on year).

Earnings(Change of 30% or more in revenue or profit/loss structure (15% for large companies))· FILED 2026-03-03· RCEPT 20260303801368

US$239MRevenue
−15%Revenue vs a year earlier
US$44.2MOperating profit

Converted at 1 USD ≈ ₩1,452.27 (filing-date rate, 2026-03-03 close)

What happened

Dentium reported consolidated results for FY2025: revenue of US$239M (−15% year on year), operating profit of US$44.2M (−34.9% year on year) and net income of US$11.5M (−76.9% year on year).

Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.

RevenueUS$239M
Revenue vs a year earlier−15%
Operating profitUS$44.2M
Net incomeUS$11.5M
PeriodFY2025 (consolidated)
Filed2026-03-03, Change of 30% or more in revenue or profit/loss structure (15% for large companies)
SourceDART rcept 20260303801368 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-03-03 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.